Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Kronos Bio Inc
KRONCurrent price
0.85 USD
+0.001 USD (+0.12%)
Last closed
0.88 USD
Company
kronosbio.com
ISIN
US50107A1043
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
52 494 480 USD
Yield for 12 month
-14.90 %
1Y
3Y
5Y
10Y
15Y
KRON
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule therapeutics to treat cancer and other serious diseases in the United States. It is developing KB-9558, a p300 KAT inhibitor development candidate which is in preclinical development for the treatment of multiple myeloma, as well as HPV-driven tumors; and KB-7898, a p300 KAT inhibitor, which is in preclinical development for the treatment of Sjogren's disease. The company was incorporated in 2017 and is headquartered in San Mateo, California. Address: 1300 So. El Camino Real, San Mateo, CA, United States, 94402
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2.25 USDP/E ratio
–Dividend Yield
–Current Year
+9 848 000 USD
Last Year
+6 288 000 USD
Current Quarter
+2 270 000 USD
Last Quarter
+2 370 000 USD
Current Year
+9 848 000 USD
Last Year
+6 288 000 USD
Current Quarter
+2 270 000 USD
Last Quarter
+2 370 000 USD
Key Figures KRON
1 year
3 years
5 years
10 years
EBITDA
-61 716 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-23.48 %
PEG Ratio
–
Return On Equity TTM
-69.80 %
Wall Street Target Price
2.25 USD
Revenue TTM
9 848 000 USD
Book Value
1.45 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-0.70 %
Dividend Yield
–
Gross Profit TTM
9 848 000 USD
Earnings per share
-1.43 USD
Diluted Eps TTM
-1.43 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics KRON
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History KRON
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
3:2
Payout Ratio TTM
–
Last Split Date
03.11.2003
Stock Valuation KRON
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
5.33
Enterprise Value EBITDA
0.81
Price Book MRQ
0.60
Financials KRON
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators KRON
For 52 weeks
0.69 USD
1.60 USD
50 Day MA
0.90 USD
Shares Short Prior Month
747 980
200 Day MA
0.99 USD
Short Ratio
3.81
Shares Short
611 610
Short Percent
1.32 %
BeatStart